We are live on ! Find out more
CDTX

Cidara Therapeutics

Delisted

CDTX was delisted on the 6th of January, 2026.

Name Holding Trade Value Shares
Change
Change in
Stake
BB
1
BB Biotech
Switzerland
$10.1M
BI
2
BVF Inc
California
$8.49M
OFM
3
Omega Fund Management
Massachusetts
$6.64M
IVM
4
InterWest Venture Management
California
$5.97M
FM
5
Frazier Management
Washington
$5.77M
OM
6
Opaleye Management
Massachusetts
$5.28M
AC
7
Aisling Capital
New York
$4.49M
Fidelity Investments
8
Fidelity Investments
Massachusetts
$3.96M -$2.52M -28,609 -39%
Vanguard Group
9
Vanguard Group
Pennsylvania
$2.91M +$379K +4,299 +15%
SCM
10
Stonepine Capital Management
Oregon
$2.89M +$1.02M +11,530 +54%
MIM
11
Monashee Investment Management
Massachusetts
$2.12M
GIM
12
Granahan Investment Management
Massachusetts
$2.11M +$107K +1,207 +5%
ACM
13
Alethea Capital Management
Washington
$1.92M +$1.45M +16,413 +301%
Millennium Management
14
Millennium Management
New York
$1.92M -$1.26M -14,288 -40%
PM
15
Prosight Management
Texas
$1.43M -$3.68M -41,690 -72%
FI
16
Fosun International
China
$1.36M +$1.35M +15,334 New
Renaissance Technologies
17
Renaissance Technologies
New York
$1.36M +$108K +1,220 +9%
RSCM
18
Rock Springs Capital Management
Maryland
$1.32M
BlackRock
19
BlackRock
New York
$1.26M -$91.5K -1,037 -7%
RJA
20
Raymond James & Associates
Florida
$1.05M +$194K +2,196 +22%
DCM
21
DAFNA Capital Management
California
$936K
RJFSA
22
Raymond James Financial Services Advisors
Florida
$935K +$194K +2,197 +26%
WFI
23
West Family Investments
California
$880K +$203K +2,306 +30%
BCM
24
Bridgeway Capital Management
Texas
$788K +$375K +4,250 +90%
TCM
25
Tekla Capital Management
Massachusetts
$699K